Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Inc

CRNX

Market Cap$3.27B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Crinetics Pharmaceuticals IncCrinetics Pharmaceuticals Inc-10.1--33%-0.1
$-5.46

Current Fair Value

115.4% downside

Overvalued by 115.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$3.27 Billion
Enterprise Value$3.00 Billion
Dividend Yield$0 (0%)
Earnings per Share$-3.69
Beta0.62
Outstanding Shares80,091,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-10.15
PEG-30.1
Price to Sales-
Price to Book Ratio3.55
Enterprise Value to Revenue2889.55
Enterprise Value to EBIT-9.75
Enterprise Value to Net Income-11
Total Debt to Enterprise0.02
Debt to Equity0.07

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Crinetics Pharmaceuticals Inc

CEO: R. Scott Struthers